United States Next Generation Sequencing Platform Market was valued at USD 3.8 Billion in 2022 and is projected to reach USD 9.4 Billion by 2030, growing at a CAGR of 12.5% from 2024 to 2030.
The Next Generation Sequencing (NGS) platform market in the US is rapidly expanding, driven by significant advancements in sequencing technologies. As industries continue to leverage NGS in diverse sectors, including healthcare, agriculture, and biotechnology, the demand for cutting-edge sequencing platforms grows exponentially. These platforms are essential for enhancing the accuracy, speed, and efficiency of genomic data analysis, offering a wealth of opportunities for innovation and scientific breakthroughs.
The US Next Generation Sequencing Platform Market is witnessing increasing adoption, with the healthcare industry being one of the largest drivers. Hospitals, research institutions, and pharmaceutical companies are actively incorporating NGS technology into clinical diagnostics, precision medicine, and drug discovery. With the ability to sequence entire genomes in a fraction of the time it took just a few years ago, NGS is revolutionizing personalized medicine by offering more accurate and cost-effective solutions for disease diagnosis and treatment.
Industries such as agriculture are also capitalizing on NGS technologies. Crop breeding, livestock genomics, and pest control are just a few areas where NGS is being applied to enhance productivity and sustainability. The ability to analyze complex genetic data allows for more efficient breeding programs and the development of genetically modified organisms that are resistant to disease or adverse environmental conditions.
As the demand for NGS platforms increases, so do the requirements from various industries. A major trend in the market is the need for platforms that offer high throughput and improved data accuracy, which can handle larger datasets while reducing errors. Another key requirement is the ability to integrate NGS technology into existing workflows, ensuring a seamless transition from traditional methods to advanced genomic sequencing systems. Moreover, affordability remains a priority, as smaller businesses and institutions seek to invest in scalable and cost-effective solutions.
With the growing importance of genomic data across industries, the US Next Generation Sequencing Platform Market will continue to evolve, presenting a wealth of opportunities for developers and businesses alike. The industry is poised for further expansion as technological advancements and industry needs continue to align, providing a fertile ground for innovation and collaboration in the NGS space.
Get an In-Depth Research Analysis of the US Next Generation Sequencing Platform Market Size And Forecast [2025-2032]
Â
Illumina
Thermo Fisher Scientific
Beckman Coulter
Roche Sequencing
Eurofins Scientific
Bio-Rad Laboratories
Beijing Berry Genomics
Helicos
Macrogen
BGI
PerkinElmer
Genewiz
Takara Bio
SciGenom Labs
Novogene
Personalis
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Next Generation Sequencing Platform Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Next Generation Sequencing Platform Market
Semi-Conductor Sequencing
Illumina Sequencing
Single-Molecule Real-Time (SMRT) Sequencing
Ion Torrent Sequencing
Ligation-Based Sequencing
Reagents
Instruments
Consumables
Software
Services
Oncology
Infectious Disease
Rare Genetic Disorders
Pharmacogenomics
Personalized Medicine
Academic and Research Institutions
Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Hospitals and Diagnostic Centers
Contract Research Organizations (CROs)
Sample Preparation
Sequencing
Data Analysis
Data Interpretation
Storage and Management
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Next Generation Sequencing Platform Market Research Analysis
1. Introduction of the US Next Generation Sequencing Platform Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Next Generation Sequencing Platform Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Next Generation Sequencing Platform Market, By Type
6. US Next Generation Sequencing Platform Market, By Application
7. US Next Generation Sequencing Platform Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Next Generation Sequencing Platform Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/